MétaCan
Menu
Back to cohort
Record W3004839765 · doi:10.1101/2020.01.29.20019521

A genetic model of ivabradine recapitulates results from randomized clinical trials

2020· preprint· en· W3004839765 on OpenAlexafffund
Marc‐André Legault, Johanna Sandoval, Sylvie Provost, Amina Barhdadi, Louis‐Philippe Lemieux Perreault, Sonia Shah, R Thomas Lumbers, Simon de Denus, Benoît Tyl, Jean‐Claude Tardif, Marie‐Pierre Dubé

Bibliographic record

VenuemedRxiv · 2020
Typepreprint
Languageen
FieldMedicine
TopicHeart rate and cardiovascular health
Canadian institutionsUniversité de MontréalMontreal Heart Institute
FundersNational Health and Medical Research CouncilCanadian Institutes of Health ResearchAmarin CorporationMedical Research CouncilSanofiGlaxoSmithKlineServierUniversité de MontréalPfizerAstraZenecaUK Research and InnovationEli Lilly and Company
KeywordsIvabradineMedicineInternal medicineCardiologyAtrial fibrillationHeart failureMyocardial infarctionHazard ratioMendelian randomizationClinical endpointHeart rateRandomized controlled trialConfidence intervalGenetic variantsBlood pressureGeneticsGenotype

Abstract

fetched live from OpenAlex

ABSTRACT Background Naturally occurring human genetic variants provide a valuable tool to identify drug targets and guide drug prioritization and clinical trial design. Ivabradine is a heart rate lowering drug with protective effects on heart failure despite increasing the risk of atrial fibrillation. In patients with coronary artery disease without heart failure, the drug does not protect against major cardiovascular adverse events prompting questions about the ability of genetics to have predicted those effects. This study evaluates the effect of a mutation in HCN4 , ivabradine’s drug target, on safety and efficacy endpoints. Methods We used genetic association testing and Mendelian randomization to predict the effect of ivabradine and heart rate lowering on cardiovascular outcomes. Results Using data from the UK Biobank and large GWAS consortia, we evaluated the effect of a heart rate-reducing genetic variant at the HCN4 locus encoding ivabradine’s drug target. These genetic association analyses showed increases in risk for atrial fibrillation (OR 1.09, 95% CI: 1.06-1.13, P=9.3 ×10 −9 ) in the UK Biobank. In a cause-specific competing risk model to account for the increased risk of atrial fibrillation, the HCN4 variant reduced incident heart failure in participants that did not develop atrial fibrillation (HR 0.90, 95% CI: 0.83-0.98, P=0.013). In contrast, the same heart rate reducing HCN4 variant did not prevent a composite endpoint of myocardial infarction or cardiovascular death (OR 0.99, 95% CI: 0.93-1.04, P=0.61). Conclusion Genetic modelling of ivabradine recapitulates its benefits in heart failure, promotion of atrial fibrillation, and neutral effect on myocardial infarction. CONDENSED ABSTRACT The effects of drugs can sometimes be predicted from the effects of mutations in genes encoding drug targets. We tested the effect of a heart rate reducing allele at the HCN4 locus encoding ivabradine’s drug target and found results coherent with the SHIFT and SIGNIFY clinical trials of ivabradine. The genetic variant increased the risk of atrial fibrillation and cardioembolic stroke and protected against heart failure in a competing risk model accounting for the increased risk of atrial fibrillation. The variant had a neutral effect on a composite of myocardial infarction and cardiovascular death.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.103
metaresearch head score (Gemma)0.158
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.103
Threshold uncertainty score0.546

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1030.158
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0050.008
Bibliometrics0.0020.002
Science and technology studies0.0010.003
Scholarly communication0.0030.003
Open science0.0040.002
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.0140.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.231
GPT teacher head0.426
Teacher spread0.195 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes2
Has abstractyes

Explore more

Same venuemedRxivSame topicHeart rate and cardiovascular healthFrench-language works237,207